Neuropeptide Y (NPY), 1 a 36-amino acid residue peptide isolated from porcine brain (1, 2) , is one of the most abundant and widely distributed neuropeptides in the central and peripheral nervous systems where it is co-localized with noradrenaline and ATP (3) . NPY modulates numerous physiological processes including regulation of cardiovascular and renal functions, intestinal motility, memory, anxiety, seizures, feeding, circadian rhythms, and nociception (4 -6) . From expression cloning and pharmacological studies with various truncated peptide fragments or with endogenously produced peptide YY (PYY) and pancreatic polypeptide (PP), 5 distinct NPY receptor subtypes have been so far identified: Y 1 , Y 2 , Y 4 , Y 5 , and y 6 (6) . The most common actions of these receptor subtypes are inhibition of adenylyl cyclase via pertussis toxinsensitive GTP-binding proteins G i /G o and/or phospholipase C activation and mobilization of Ca 2ϩ from intracellular stores. The wide spectrum of expression of the NPY Y 1 receptor subtype and data from knock-out studies suggests that the Y 1 receptor mediates many of the physiological and pathophysiological actions of NPY (7) (8) (9) . However, the physiological role and potential therapeutic implications of NPY and the Y 1 receptor have been difficult to establish due to a lack of selective pharmacological tools. Thus, elucidation of the mechanisms involved in the regulation of Y 1 receptors should contribute to a better understanding of the physiological roles of NPY.
Prolonged activation of G protein-coupled receptors (GPCRs) leads to a greatly decreased sensitivity of the receptor to a subsequent agonist challenge (10) . This phenomenon, termed desensitization, is a general physiological mechanism by which receptors adapt to a changing environment. The molecular mechanisms that lead to agonist-dependent desensitization of G protein-coupled receptors are not fully defined, but several distinct events are involved, including uncoupling of receptors from their heterotrimeric G proteins and reduction in the number of receptors at the cell surface by either internalization or down-regulation which may be associated with degradation (11) (12) (13) . Internalization is thought to be initiated by receptor phosphorylation by G protein-coupled receptor kinases and binding of ␤-arrestin to phosphorylated receptors, leading to targeting to clathrin-coated pits (14, 15) . For example, internalization of receptors has been suggested to be the mechanism for somatostatin receptor desensitization (16) . However, the dynamic relationships between internalization, desensitization, and down-regulation are far from being well understood.
Desensitization of NPY receptor responsiveness occurs after NPY exposure in isolated organ preparations (17) (18) (19) (20) (21) . Rapid desensitization of NPY-stimulated Ca 2ϩ mobilization occurs in HEL cells and involves multiple effectors including PKC and tyrosine kinase (22) . However, neither the underlying molecular mechanisms nor the intracellular trafficking pathways involved are well known. Recent studies indicate that endogenous Y 1 receptors in SK-N-MC neuroblastoma (23) and guinea pig Y 1 but not Y 2 receptors expressed in CHO cells (24) are internalized. On the other hand, in pharmacological studies, hNPY Y 4 receptors expressed in CHO cells were resistant to desensitization and internalization (25) , although in radioligand studies, rat Y 4 receptors expressed in CHO cells were found to be internalized (24) .
The development of fusion proteins tagged with green fluorescent protein (GFP) allows real time analysis of membrane receptor trafficking, including synthesis and degradation, in single cells (26) . In the present work, EGFP was fused to the NH 2 -terminal of the full-length human NPY Y 1 and Y 2 receptors and these chimeric constructs were transfected into HEK293 cells. The functional properties of fluorescent hNPY Y 1 receptors were similar to those of wild-type hNPY Y 1 receptors after transfection in these cells, and were the same as found for NPY Y 1 receptor-mediated responses in SK-N-MC neuroblastoma cells (27, 28) . By measuring the EGFP fluorescence of chimeric receptors after challenge with hNPY, we report that human NPY Y 1 but not Y 2 receptors undergo rapid clathrin-dependent internalization in an endosomal recycling compartment.
EXPERIMENTAL PROCEDURES
Cell Culture, cDNA Constructs, Expression, and Selection-Control HEK293 cells and HEK293 cells expressing hNPY Y 1 , EGFP-hNPY Y 1 and EGFP-hNPY Y 2 receptors were cultured to ϳ80% confluence in T-75 flasks in minimal essential medium with Earle's salt supplemented with 10% fetal calf serum, 2 mM glutamine, and 1% antibiotics (penicillin/streptomycin).
cDNA of human NPY Y 1 and Y 2 receptors (29, 30) were kindly provided by Prof. H. Herzog (Garvan Institut of Medical Research, Sydney, Australia). The hNPY Y 1 receptor sequence was subcloned in the expression vector pCEP4 (Invitrogen) between the HindIII and NotI sites to yield pCEP4-hNPY Y 1 . The sp-EGFP sequence was excised from pCEP4-sp-EGFP-NK 2 R (31) by BglII and HindIII restriction enzymes. The hNPY Y 1 receptor sequence was excised from pCEP4-hNPY Y 1 using BglII and BamHI. The two sequences were subcloned in pCEP4 between the HindIII and BamHI sites to yield pCEP4-sp-EGFP-hNPY Y 1 . HEK293 cells were transfected by calcium phosphate precipitation (32) and selected with 4000 g/ml hygromycin B. EGFP-hNPY Y 1 and hNPY Y 1 receptors were expressed stably for about 2 months (10 cell passages). EGFP-hNPY Y 2 receptors were constructed and transfected in HEK293 cells using analogous procedures.
cAMP Measurements-NPY receptor coupling to adenylyl cyclase was investigated by measuring the dose-dependent inhibitory effects of NPY and related peptide analogues on forskolin-stimulated cAMP accumulation. Near confluent HEK293 cultures expressing wild type hNPY Y 1 or EGFP-hNPY Y 1 receptors were harvested and seeded in 24-well plates coated with collagen (60 g/ml) at an initial density of 50,000. After 3-4 days of culture (ϳ80% confluency), the cells were treated as previously described for CHP 234 neuroblastoma cells (33) . Briefly, cells were washed with 0.5 ml of PBS (in mM: 137 NaCl, 2.7 KCl, 0.9 CaCl 2 , 0.5 MgCl 2 , 6.5 Na 2 HPO 4 , 1.5 KH 2 PO 4 , pH 7.2), and then incubated at 37°C for 10 min with 0.5 ml assay buffer (in mM: 150 NaCl, 5 KCl, 2.5 CaCl 2 , 1.2 KH 2 PO 4 , 1.2 MgSO 4 , 25 NaHCO 3 , 10 HEPES, 10 mg/ml BSA, pH 7.4). After removal of buffer, 0.45 ml of fresh buffer containing 0.5 mM 3-isobutyl-1-methyl-xanthine (IBMX) was added for 10 min and cells were exposed to 10 M forskolin without and with peptides (10 Ϫ12 -10 Ϫ6 M) for 20 min at 37°C. We found that at this submaximal forskolin concentration, cAMP levels reach a maximum within 20 min (Fig. 1E) . The reaction was stopped by addition of 1 volume of ice-cold 0.2 M HCl. Cells were further disrupted by sonication and suspensions were centrifuged at 14,000 ϫ g for 15 min. The resulting supernatants were stored at Ϫ20°C until determination of cAMP by radioimmunoassay (34) . To study agonist-dependent desensitization of the inhibition of adenylyl cyclase activity, cells were preincubated for 10 min at 37°C without or with either 1 or 100 nM hNPY. The cells were then washed with incubation medium to remove unbound hNPY during 10 min and thereafter assayed as above using different concentrations of hNPY for inhibition of forskolin-stimulated cAMP accumulation.
Single-cell Measurements of [Ca 2ϩ ] i -For imaging studies, HEK293 cells transfected with EGFP-hNPY Y 1 receptors were plated at low density (5-8 ϫ 10 5 cells/dish) in culture dishes in which a 2-cm diameter hole had been cut in the base and replaced by a thin (0.17-mm) glass coverslip. Measurements of [Ca 2ϩ ] i were made as previously described (33) . Briefly, cells were incubated for 60 min at 37°C in complete medium containing in addition 2.5 M fura 2/acetoxymethyl ester (fura 2/AM), then washed and left equilibrated for 10 min in normal external bath solution (in mM: NaCl, 140; KCl, 5; CaCl 2 , 2; MgCl 2 , 2; glucose, 11; HEPES, 10; pH 7.3 with NaOH). Single-cell fluorescence measurements were made at 37°C on an inverted microscope (Nikon Diaphot) using a ϫ40 oil immersion objective (Nikon UV-Fluor, numerical aperture 1.3) and an imaging system (Imstar, Paris, France). Fura-2 was excited alternately at 340 and 380 nm using a 100-watt Hg lamp. Emitted fluorescence was filtered at 510 Ϯ 20 nm using a bandpass filter (Nikon) and measured with a Darkstar-800 intensified CCD camera (Photonics Sciences, Millham, United Kingdom). Images were digitized onto a computer and analyzed using Imstar software. Ratiometric Ca 2ϩ images were generated at 3-s intervals, using 4 averaged images at each wavelength. After background subtraction, [Ca 2ϩ ] i was averaged from pixels within manually outlined cell areas. Values of [Ca 2ϩ ] i were calculated as reported before (33) . NPY or carbachol was locally microperfused during 1 min by pressure-ejection (10 kPa) from fine diameter (2 m) puffer pipettes positioned ϳ100 -20 m from the cell. For washout between successive agonist applications, the bath (volume 1.5 ml) was superfused at ϳ1 ml/min. 1 and Y 2 Receptors-Transfected HEK293 cells were grown on 35-mm plastic dishes and when needed, preincubated with different drugs in complete medium. Cells were then washed with PBS, harvested after incubation in a PBS-EDTA, 5 mM buffer, pH 7.4, and resuspended in Krebs-Ringer buffer containing or not drugs used for preincubation. Fluorescence acquisitions were made from cell suspensions using a spectrofluorimeter (Fluorolog, SPEX) equipped with a 450-watt Xe lamp, a double grating excitation monochromator, and a single grating emission monochromator. Slits were set to 4 mm yielding bandwidths of 7.2 nm at excitation and 14.4 nm at emission. Data were acquired with a photon counting photomultiplier (linear up to 10 7 counts/s). Unless otherwise stated, cell suspensions (10 6 cells/ml) were placed in a 1-ml cuvette with magnetic stirring and maintained at 37°C in a thermostatted cuvette handler. Time base recordings were typically made every 1 s. 20 Hepes, 1 mg/ml BSA, pH 7.4). Cells were then starved by 1 h incubation in serum-free medium. The cells were then incubated for periods ranging from 0 to 60 min in Krebs-Ringer buffer containing 20 g/ml transferrin-Texas Red with or without 100 nM hNPY at 37°C. Transferrin uptake was stopped by placing cells on ice and washing them immediately with ice-cold Krebs-Ringer buffer. The cells were then fixed in 4% paraformaldehyde/Krebs-Ringer buffer (without glucose and BSA) for 15 min at 4°C and then incubated for 15 min in NH 4 Cl 50 mM toquench any remaining paraformaldehyde and remove cellular autofluorescence. Coverslips were mounted onto microscope slides using an anti-fading agent, Mowiol (Calbiochem). Cells were observed with an inverted microscope (Nikon Eclipse TE300) and a laser scanning confocal imaging system (Bio-Rad MRC 1024 ES) using a Plan Apo 60 ϫ 1.20 numerical aperture water immersion objective (Nikon). Electronic zoom was 2, the pinhole was 2.7, and the pixel size was 0.275 m. Excitation was from a 30 mW Kr/Ar laser at 10% power. Each stack of two-dimensional images was acquired sequentially in the green channel (PMT2, excitation 488, emission 522 nm) and in the red channel (PMT1, excitation 568 nm, emission 605 nm), before stepping (0.3 m) the objective in the Z axis. For lysosome/EGFP-hNPY Y 1 receptor co-localization, images were acquired from living cells. Cells were split and grown on collagen-coated glass coverslips which formed the base of 35-mm plastic dishes. On the day of experiment, cells were washed twice with Krebs-Ringer buffer, and then incubated for 0 to 60 min in buffer containing 50 nM LysoTracker Red (Molecular Probes) with or without 100 nM hNPY at 37°C. The reaction was stopped by placing cells on ice, and washing them with ice-cold Krebs-Ringer buffer. Images were acquired as described for transferrin-Texas Red-EGFP-hNPY Y 1 receptor co-localization.
Fluorescence Measurements of Agonist-induced Internalization of EGFP-hNPY Y
Image Analysis-Co-localization analysis was done using AnalyzeAVW 3.0 software installed on a Silicon Graphics work station. The product of red (transferrin-Texas Red or LysoTracker Red) and green (EGFP) images was calculated, and co-localized yellow regions of interest were defined using a threshold of 10% of maximum product intensity. Volume measurements were made from image stacks using inhouse developed View3d software in the PV Wave environment. After segmentation and suppression of isolated voxels using a binary filter, the volume and intensity of co-localized voxels were calculated.
Assessment of Receptor Stability by Pulse-chase Experiments-HEK293 cells transfected or not with EGFP-hNPY Y 1 receptors were plated on 6-well plates (Falcon) pre-coated with collagen in 3 ml of complete medium and grown for 2 days. Cells were then preincubated for 1 h at 37°C in 1 ml/well labeling medium without fetal calf serum (minimal essential medium without methionine and without cysteine, Invitrogen) and, unless otherwise stated, radiolabeled for 90 min in 1 ml/well labeling medium ϩ 1% fetal calf serum ϩ 0.1 mCi/well [
35 S]methionine-cysteine (Promix, Amersham Biosciences, Inc.) and then washed for 15 min in chase medium (complete minimal essential medium supplemented with 1 ϫ cold methionine ϩ cysteine and 20 M cycloheximide). Cells were exposed or not to 400 nM hNPY in 1 ml of Krebs-Ringer buffer for 10 min in the incubator. Thereafter, they were incubated in 1 ml of chase medium containing 100 M cycloheximide for 0 to 7 h. At the end of the chase, cells were detached from the substratum with 1.6 ml of Versene buffer (PBS ϩ 5 mM EDTA) and centrifuged in 2-ml tubes at low speed (825 ϫ g, 3 min, 4°C). The cell pellet was then processed for immunoprecipitation.
Immunoprecipitation and Immunostaining of EGFP-hNPY Y 1 Receptors-Each cell pellet was resuspended in 500 l of cold lysis buffer (150 mM NaCl, 1.5 mM MgCl 2 , 10% glycerol, 5 mM EDTA, 50 mM Hepes, pH 7.5) supplemented with 1 mM dithiothreitol and 1 tablet of complete EDTA-free protease inhibitor (for 10 ml of buffer, Roche Molecular Biochemicals). A post-nuclear supernatant was prepared by passing the cells 100 times through a 22-guage syringe and discarding the pelleted material obtained after 10 min centrifugation at 367 ϫ g. The membranes of the supernatant were solubilized by adding 1% Triton X-100 and 0.2% SDS and vortexing for 30 min at room temperature. Unsolubilized material was pelleted by centrifugation (15,000 ϫ g, 15 min, 4°C) and discarded. The supernatant was incubated overnight at 4°C with a monoclonal mouse anti-GFP antibody (1 g/ml, Roche Molecular Biochemicals). Protein A-Sepharose (45 mg) prewashed in H 2 O was equilibrated in washing buffer (lysis buffer ϩ 1% Triton X-100) and incubated overnight with 800 l of washing buffer ϩ 1% BSA ϩ 0.2% SDS ϩ 10% cold HEK lysate. The next day, the EGFP-hNPY Y 1 -anti-GFP complex was bound to Protein A-Sepharose (7.5 mg/1 ml) for 1 h at 4°C and sedimented by 1 min centrifugation at 367 ϫ g. The immunoprecipitated complex was washed 3 times and resuspended twice in 30 l of Laemmli buffer (100 mM Tris-HCl, pH 6.8, 5 mM EDTA, 100 mM dithiothreitol, 4% SDS, 10% glycerol). Samples were vortexed for 30 min at room temperature and heated at 55°C for 10 min prior to loading on a 10% SDS-PAGE gel. For quantification, gels were blotted on polyvinylidene difluoride membranes and analyzed for radioactivity after 48 h exposition in a PhosphorImager cassette. For immunoblotting, blots were incubated with an affinity purified polyclonal antibody against EGFP made in our laboratory, followed by incubation with a goat anti-rabbit secondary antibody conjugated to horseradish peroxydase (Amersham Biosciences Inc.). Detection was carried out using enhanced chemiluminescence (SuperSignal TM WestPico, PerboScience, France).
Internalization Kinetics of EGFP-hNPY Y 1 Receptors Measured Using Anti-GFP Antibodies-Cells expressing EGFP-hNPY Y 1 receptors
were suspended in 20 ml of Krebs-Ringer buffer at a concentration of 10 6 cells/ml and the suspension was separated into 2 tubes of 10 ml. 100 nM NPY was added to one of the tubes and at times 0, 1, 2, 3, 5, 10, 20, and 30 min later, 900 l of the cell suspension were collected from both tubes and fixed by transfer to a 2-ml tube containing 900 l of 8% paraformaldehyde and 0.2% sodium azide in PBS for 10 min at room temperature. After fixation, cells were pelleted by centifugation (3 min, 2000 ϫ g) at 4°C and resuspended in 1 ml of PBS ϩ 1% BSA on ice for 10 min to 2 h to block nonspecific antibody labeling. Immunolabeling of EGFP-hNPY Y 1 receptors expressed at the cell surface was done using a monoclonal mouse anti-GFP (Roche Molecular Biochemicals; 1/1000 dilution) for 30 min at room temperature. Cell were then washed 3 times with 1 ml of PBS ϩ 1% BSA and secondary labeling done using a R-phycoerythrin-conjugated AffiniPure F(abЈ)2 fragment goat antimouse IgG (Immunotech, Marseille; 1/1000). Samples were washed 3 times in 1 ml of PBS, fixed for 3 min in PBS ϩ 4% paraformaldehyde, resuspended in 1 ml of PBS, and stored overnight. Phycoerythrin (PE) staining was quantified by flow cytometric analysis (10,000 cells per sample) on a cytometer (FACStar, Becton-Dickinson). Mean PE fluorescence intensity was calculated only from cells having high EGFP intensities using FACStar data software, after subtraction of nonspecific staining by the two antibodies measured on nontransfected cells and correction for baseline variations using EGFP-hNPY Y 1 cells not exposed to agonist.
Peptides and Chemicals-hNPY, hNPY-(13-36), hPYY, and hPP were from Neosystem (Strasbourg, France). All other chemicals were from Sigma. BIBP3226 and BIIE0246 were kindly supplied by Dr. H. Doods (Boehringer Ingelheim, Biberach, Germany). 1 Receptors-HEK293 cells, which lack endogenous Y 1 receptors, were transfected with native hNPY Y 1 or fluorescent EGFP-hNPY Y 1 receptors. Expression of fluorescent receptors was confirmed by the characteristic excitation and emission spectra of EGFP (data not shown), and plasma membrane localization was verified in confocal micrographs (see Fig. 7 ). To determine whether the transfected receptors were functional, coupling to adenylyl cyclase was assessed by measuring the inhibition of forskolin-stimulated cAMP accumulation following receptor activation ( Desensitization of Adenylyl Cyclase Responses-To study whether prior exposure to hNPY could desensitize the inhibitory effect of hNPY on forskolin-stimulated cAMP accumulation, EGFP-hNPY Y 1 cells were preincubated for 10 min with either 1 or 100 nM hNPY, washed for 10 min, and then assayed for cAMP levels using the protocol described above. Such agonist pretreatment resulted in a marked decrease in the maximum inhibitory effect of hNPY on forskolin-stimulated cAMP accumulation, from 85% for nontreated cells to 40 and 10% in 1 and 100 nM pretreated cells, respectively (Fig. 1F) , consistent with prior agonist exposure leading to subsequent desensitization of the agonist-induced effect. However, it should be noted that due to the variability of cAMP levels between experiments, results were normalized to the forskolin-stimulated cAMP levels for each experiment. Thus, for cells preincubated 10 min with 1 and 100 nM hNPY, forskolin-stimulated cAMP levels were decreased by 38 and 59%, respectively, when compared with control nontreated cells. (Fig. 2C) . To distinguish between Y 1 receptor desensitization and depletion of internal Ca 2ϩ stores, we determined whether carbachol was able to induce an increase in Ca 2ϩ 3-5 min after the absence of response to a second challenge with hNPY. In these conditions, carbachol always produced a second increase in [Ca 2ϩ ] i (Fig. 2, A and B) , indicating that intracellular Ca 2ϩ stores were not depleted and that the Ca 2ϩ mobilization system was functional and available for endogenous muscarinic receptor-mediated activation. Thus, within 3 min, EGFP-hNPY Y 1 receptors were desensitized following single exposures to agonist, and this desensitization lasted for at least 30 min.
RESULTS

Functional and Pharmacological Properties of Chimeric EGFP-hNPY Y
Single-cell Measurements of NPY-induced Changes in
Agonist-induced Decrease in EGFP-hNPY Y 1 Receptor Fluorescence-Addition of 100 nM hNPY to a suspension of EGFP-hNPY Y 1 expressing cells induced a rapid decrease in EGFP fluorescence (Fig. 3A) that slowly recovered during the 30-min measurement period. This decrease in fluorescence was not observed in the presence of the Y 1 antagonist BIBP3226 (10 M) nor for EGFP-hNPY Y 2 expressing cells (Fig. 3A) . Note that the functionality of EGFP-hNPY Y 2 receptors was also verified using agonist-stimulated inhibition of forskolin-stimulated cAMP production (not shown). The peak decrease in fluorescence was concentration-dependent, with an EC 50 value of 6.02 nM for hNPY (Fig. 3B) . The maximal decrease in fluorescence reached a plateau value of about 10% at high NPY concentrations. In agreement with a G i/o -linked mechanism, the hNPY-induced decrease in fluorescence was reduced by more than 80% after PTX pretreatment (Fig. 3C) . The full Y 1 agonists hPYY and [Leu 31 ,Pro 34 ]NPY induced changes in fluorescence similar to those for hNPY, while hNPY-(13-36) was less efficacious (40% maximal effect) and hPP was ineffective (Fig. 3D) . These data show that the observed agonist-dependent variation of fluorescence is associated with Y 1 receptor activation.
Decrease in EGFP-hNPY Y 1 Receptor Fluorescence Is Likely Due to an Acid Environment-A plausible explanation for the decrease of EGFP-hNPY Y 1 receptor fluorescence is that upon activation, subsequent internalization of the receptor brings EGFP into a different environment, for example, in acidic endosomal compartments, where it is less fluorescent. Indeed, EGFP fluorescence is sensitive to pH (35) , being reduced in acidic conditions. We tested this possibility using monensin, an ionophore known to inhibit trafficking toward endosomes (36) by collapsing Na ϩ /H ϩ gradients responsible for endosomal acidification (37) . After preincubation of EGFP-hNPY Y 1 receptor expressing cells with monensin, the hNPY-induced decrease of fluorescence was no longer detected (Fig. 4A ). This suggests that activated EGFP-hNPY Y 1 receptors are internalized to acidic endosomal compartments.
NPY-induced Decrease in Fluorescence Reflects EGFP-hNPY Y 1 Receptor Internalization-To test the hypothesis that the decrease in fluorescence is due to a change of EGFP environment following receptor endocytosis, the effect of hNPY was investigated at various temperatures and in the presence of inhibitors of internalization. As expected for an energy-dependent internalization process, the kinetics of the NPY-induced decrease in fluorescence were slower when the temperature was decreased from 37°C to 30°C and 25°C (values for t1 ⁄2 , the half-time to peak decrease, were 107 Ϯ 3, 181 Ϯ 8, and 337 Ϯ 21 s, respectively), and notably, below 20°C, fluorescence decreases were partially to fully inhibited (Fig. 4B) . Concanavalin A, a nonspecific inhibitor of internalization (38) , greatly reduced the amplitude of the NPY-induced fluorescence decrease (Fig. 4C) . Sucrose, a more specific blocker of clathrin-mediated internalization (39, 40) was used to investigate the possible internalization pathway. At 400 mM, sucrose completely blocked the rapid initial decrease of fluorescence (Fig. 4D) , with the residual slow drift of fluorescence intensity seen after 4 min possibly reflecting an incomplete sucrose effect, as previously proposed (41) . Sucrose does not affect receptor functionality since NPY-induced inhibition of cAMP accumulation was unchanged in the presence of 400 mM sucrose (data not shown). These observations support the notion that activated EGFPhNPY Y 1 receptors are internalized via the pathway involving clathrin-coated pits. 
Decrease in EGFP-hNPY Y 1 Receptor Fluorescence Is Not
Due to Degradation-In an effort to characterize the intracellular trafficking pathway of internalized receptors after agonist exposure, we tested whether receptor degradation contributes to the decrease in fluorescence. In the absence of hNPY, newly synthesized EGFP-hNPY Y 1 receptors in HEK293 cells were radiolabeled with [ 35 S]methionine-cysteine for 4 h and processed for immunoprecipitation using a monoclonal anti-GFP antibody. The immunoprecipitate was separated by SDS-PAGE and then transferred to a membrane for autoradiography or immunostaining with a polyclonal anti-GFP antibody (Fig. 5A) . A major radioactive band migrating at 105 kDa was specifically immunoprecipitated in cells expressing the EGFP-hNPY Y 1 chimera, but not in control untransfected cells (left columns, Fig. 5A ). This 105-kDa band from the same blot was positively immunostained with a polyclonal anti-GFP antibody (right columns, Fig. 5A ), consistent with its identification as the EGFPhNPY Y 1 receptor. Similar results were obtained for radiolabeling during 1 and 2 h (not shown). To assess EGFP-hNPY Y 1 receptor stability by pulse-chase, radiolabeling was done for 90 min, followed or not by 10 min exposure to 400 nM hNPY and periods of 0 to 7 h of chase (cold methionine-cysteine ϩ cycloheximide) before immunoprecipitation, and subsequent autoradiography and immunostaining (Fig. 5B) . Autoradiographs of the immunoprecipitated 105-kDa band clearly show that the amount of radiolabeled EGFP-hNPY Y 1 receptor was stable over 7 h both for quiescent and agonist-activated receptors (Fig.  5B) . These experiments show that the agonist-induced variations of EGFP-hNPY Y 1 receptor fluorescence very likely do not reflect protein degradation, and thus, that activated receptors are not directed to a degradative pathway.
In agreement with the pulse-chase data, the agonist-induced decrease and recovery of EGFP-hNPY Y 1 receptor fluorescence were not affected by 1-h preincubation with inhibitors of transcription (actinomycin D) and protein synthesis (cycloheximide; Fig. 6A ), indicating that de novo receptor synthesis does not contribute in a major fashion to the variations in fluorescence. Furthermore, addition of an excess of the competitive Y 1 antagonist BIBP3226 when EGFP-hNPY Y 1 receptor fluorescence intensity was minimal lead to a rapid recovery toward initial levels of fluorescence (Fig. 6B) . Taken together, these data strongly suggest that after agonist challenge, EGFP-hNPY Y 1 receptors are rapidly internalized and, rather than being degraded and synthesized de novo, they are directed toward a recycling pathway.
Internalized EGFP-hNPY Y 1 Receptors Rapidly Enter an Endosomal Recycling Pathway-To determine whether activated EGFP-hNPY Y 1 receptors are sequestered in an endosomal compartment via similar pathways as for certain other G protein-coupled receptors, the subcellular localization of EGFPhNPY Y 1 receptors was compared with that of either endocytosed transferrin-Texas Red, a marker for the recycling pathway, or LysoTracker Red, a lysosome-directed pathway marker (Fig. 7) . In the absence of agonist, EGFP-hNPY Y 1 receptors were evenly distributed along the membrane (Fig. 7,  A and C, panel 0 min) . After hNPY application, EGFP-hNPY Y 1 intensity at the plasma membrane decreased, coincident with the appearance of a punctate intracellular distribution of the EGFP signal. Co-localization of EGFP with transferrin-Texas Red was visualized as a yellow signal in the overlays (Fig. 7A , panels 5 to 60 min). At early times after agonist application, punctate co-localized EGFP/transferrin-Texas Red signals were strongest in just submembrane regions (Fig. 7A, panel 5 and 15 min), whereas at later times, co-localized signals appeared in larger structures having a more perinuclear location (Fig. 7A, panel 30 and 60 min) . In contrast, no co-localization of EGFP-hNPY Y 1 /LysoTracker Red signals was observed after hNPY application (Fig. 7C, panels 15 and 60 min) . Voxel analysis of co-localized EGFP-hNPY Y 1 /transferrin-Texas Red signals allowed reconstruction of an image product (Fig. 7A, last  row) . Such images clearly confirm that the pattern of co-localized elements evolves from a small particulate distribution toward larger structures with time. The volumes of co-localized elements were determined and classed in 3 size groups (Fig.   7B ). These size groups were chosen to correspond to endocytosis vesicles (1.5 ϫ 10 Ϫ5 to 5.99 ϫ 10 Ϫ4 m 3 ), early endosomes and sorting endosomes (6 ϫ 10 Ϫ4 to 1.99 ϫ 10 Ϫ3 m 3 ), and recycling endosomes (Ͼ2 ϫ 10 Ϫ3 m 3 ), according to literature values (42) (43) (44) . During 5-60 min after agonist application, a decrease in the smallest-sized particles (from 66 Ϯ 6 to 40 Ϯ 1%) was seen (Fig. 7B) , with a concomitant increase in the largest-sized particles (from 21 Ϯ 5 to 52 Ϯ 2%), while the number of medium-sized particles was relatively more stable. tion-To further characterize the variations of receptor fluorescence detected during the course of internalization, we quantified the relative amounts of EGFP arising from EGFP-hNPY Y 1 receptors at the cell surface with time after hNPY challenge. This was carried out by flow cytometry using anti-GFP antibodies and detection with secondary phycoerythrin-labeled antibodies on fixed cells. PE intensities were measured from cells having high levels of EGFP fluorescence (Fig. 8, A and B) . After 5 min incubation with 100 nM hNPY (Fig. 8B) , a clear shift toward lower PE intensities was observed compared with nonstimulated cells (Fig. 8A) , consistent with lower numbers of EGFP-hNPY Y 1 receptors being present at the cell surface, presumably due to internalization. These data were quantified as shown in Fig. 8C , and the full time course of the amounts of EGFP-hNPY Y 1 receptors at the cell surface after challenge with 100 nM NPY is given in Fig. 8D . Note that the variations in cell surface receptors closely follow the time course of fluorescence variations shown in Fig. 3 . In particular, the decrease in the number of cell surface receptors is maximal at 4 -5 min and reaches 25.0 Ϯ 0.5% of the total cell surface receptor population. Compared with the maximum decrease of fluorescence of about 10% (Fig. 3) , it can be estimated that GFP fluorescence is quenched by about 50 -60%, a value that is in good agreement with the reported sensitivity (35) of GFP to acid pH characteristic of endosomal compartments.
Taken together, our data obtained by recording fluorescence from cell suspensions and by confocal imaging of receptor distributions are consistent with the scheme whereby agoniststimulated EGFP-hNPY Y 1 receptors undergo rapid regulation of their surface distribution involving endocytosis and recycling pathways.
DISCUSSION
In the present study, we show that the EGFP-hNPY Y 1 receptors heterologously expressed in HEK293 cells transduce calcium responses that rapidly and completely desensitize for at least 30 min. From extensive studies on other GPCRs, desensitization has been shown to involve at least receptor phosphorylation and a decrease in the number of receptors at plasma membrane following internalization and eventually, degradation in lysosomes (13) . In an effort to further characterize the mechanisms underlying desensitization of hNPY Y 1 receptors, we constructed a fluorescent chimeric Y 1 receptor by fusing EGFP to its NH 2 -terminal. When expressed in HEK293 cells which have no endogenous Y 1 receptors, EGFP-hNPY Y 1 receptors were functional as assessed by the inhibition of forskolin-induced cyclic AMP accumulation and had a Y 1 pharmacological profile. Curiously, NPY-(13-36) is much efficacious in EGFP-hNPY Y 1 cells compared with hNPY Y 1 cells. It may be that the EGFP tag alters the functional response of the chimeric Y 1 receptor to certain ligands, perhaps by changing the protein conformation, as has been previously found for the P2Y 1 -EGFP-tagged receptor (45) . Upon agonist challenge, we found that EGFP-hNPY Y 1 fluorescence rapidly decreases and then slowly recovers and that these variations appear to be associated with rapid internalization and recycling of the receptors. In confocal micrographs, EGFP-hNPY Y 1 fluorescence co-localized with transferrin-Texas Red, a marker of the early endosome and recycling endosome pathways, while in contrast, no co-localization was detected using the lysosomal marker LysoTracker Red. This latter observation is consistent with the absence of detectable degradation of activated receptors, as assessed in our pulse-chase experiments.
Pharmacological studies on CHO cells expressing NPY Y 4 receptors show that this PP-selective receptor is resistant to desensitization and internalization (25) . This suggests that susceptibility to internalization is subtype dependent, and indeed we found no internalization of EGFP-hNPY Y 2 receptors. Similar receptor subtype differences for agonist-induced internalization have been observed. For example, ␣ 2 -adrenergic receptors transduce their signal via the G i /G o subfamily of G proteins. However, following agonist occupancy, the ␣ 2B -adrenergic receptor is rapidly and extensively internalized, whereas the ␣ 2A -adrenergic receptor does not readily redistribute to an intracellular compartment (46) . In addition, differential regulation by internalization has been observed for some receptors depending on the cell type in which they are expressed. For example, CXCR1 chemokine receptors stimulated by interleukin-8 are internalized in neutrophil-like RBL-243 cells but not in HEK293 cells (47) . This difference has been attributed to cellular factors like ␤-arrestin or G protein kinases which may be differentially expressed in different cell lines. Since we observed internalization of EGFP-hNPY Y 1 but not EGFP-hNPY Y 2 receptors in HEK293 cells, in agreement with recent studies on Y 1 and Y 2 receptors expressed in CHO cells (24) , our observations of EGFP-hNPY Y 1 receptor internalization in HEK293 cells are unlikely to be of artifactual origin.
We observed that pertussis toxin treatment, at a concentration which fully inhibited coupling to adenylyl cyclase, only partially blocked the agonist-induced decrease of EGFP fluorescence. Recently, -opioid receptor down-regulation was found to be dually regulated by two distinct and equally important signal transduction pathways, one being a G-protein and G-protein receptor kinase-dependent pathway abolished by PTX, and the other being a G protein-independent, tyrosine kinase-dependent pathway, blocked by genistein (48) . These two pathways do not interact, since when one pathway is blocked, the other remains unaffected. A possible contribution of this second G protein-independent pathway may be implicated in EGFP-hNPY Y 1 receptor internalization, given the partial effects of PTX pretreatment. This is further suggested by the incomplete effect of 0.4 M sucrose found here, as also described for GFP-tagged thyrotropin-releasing hormone receptors (41) . Internalization using clathrin-coated pits is blocked by hypertonic external solutions (39, 40) due to an abnormal formation of microcages of clathrin into normal coated pits resulting in inhibition of endocytosis. It should be noted, however, that sucrose treatment induces mitogen-activated protein kinase activation (49) which in turn can inhibit receptor internalization indirectly (50) . Thus, whether the putative G protein independent internalization pathway of EGFP-hNPY Y 1 receptors is also independent of clathrin remains to be demonstrated.
The pharmacological profile of the variations in fluorescence recorded from suspensions of agonist-stimulated cells expressing EGFP-hNPY Y 1 receptors is consistent with Y 1 receptor activation. We postulated that the rapid initial decrease in EGFP fluorescence is due to internalization of EGFP-hNPY Y 1 receptors into acidic endosomal compartments, and the inhibitory effect of the ionophore monensin agrees with this notion. That EGFP-hNPY Y 1 receptor internalization can be assessed using changes in EGFP fluorescence is supported by the temperature dependence of the fluorescence variations, being strongly decreased below 20°C (51), and by the blocking effects of concanavalin A and sucrose, well known inhibitors of clathrin-coated pit formation (38 -40) . Finally, the strikingly similar time course of the amounts of cell surface receptors after agonist challenge obtained using anti-GFP antibodies is further strong evidence that the variations in fluorescence reflect receptor internalization.
Desensitization of NPY Y 1 receptors has been most widely described in in vitro studies on isolated tissues (17) (18) (19) (20) (21) . Pretreatment of EGFP-hNPY Y 1 cells with hNPY decreased the ability of a further agonist challenge to inhibit the forskolininduced cAMP accumulation, consistent with an agonist-dependent desensitization of the adenylyl cyclase responses. We also found that EGFP-hNPY Y 1 receptor-mediated calcium responses in HEK293 cells desensitize rapidly, in agreement with earlier work (22) . It is tempting to correlate the absence of a second calcium response 3 min after an initial agonist challenge with the kinetics of EGFP-hNPY Y 1 receptor internalization. Indeed, internalization of receptors has been suggested to constitute the major mechanism for desensitization of somatostatin receptors (16) . On the other hand, rapid desensitization of the ␦-opioid receptor involves multiple pathways, including agonist-induced receptor phosphorylation and rapid internalization (52) . However, receptor phosphorylation is not an obligatory event for agonist-induced ␦-opioid receptor internalization and it has been suggested that association of arrestin with the nonphosphorylated ␦-opioid receptor triggers receptor internalization and uncoupling of the G protein from the receptor (52) . Agonist-induced rapid desensitization of the ␦-opioid receptor is completely abolished only when both of these processes are blocked (52) . Although it cannot be excluded that desensitization and internalization of the hNPY Y 1 receptor are two separate phenomena, the rapid internalization EGFP-hNPY Y 1 receptors might account for the rapid functional desensitization that we have observed. This supports the idea that rapid receptor internalization represents a physiological adaptative mechanism preventing cellular overstimulation.
The slow recovery phase of fluorescence of activated EGFPhNPY Y 1 receptors was unaltered by inhibitors of transcription and translation. This clearly shows that receptors are not appreciably neo-synthesized over the time course of our measurements, but rather suggests that internalized receptors enter a recycling pathway leading to relocalization at the cell surface. Based on our confocal images, we could not estimate the proportion of receptors that recycle directly from sorting endosomes or from the recycling compartment, although it was apparent that a significant fraction of receptors co-localize with transferrin in small punctate compartments initially and then accumulate in larger perinuclear recycling endosomes (53) . Because the pH of recycling endosomes is less acid than that of sorting endosomes, being 6.5 versus 6.0, respectively (43, 54) , and given the pH dependence of EGFP fluorescence (35) , the arrival of EGFP-hNPY Y 1 receptors in recycling endosomes probably accounts for part of the fluorescence recovery. Recycling of EGFP-hNPY Y 1 receptors to the cell surface occurs in the continued presence of agonist in fluorescence recordings, in confocal studies as well as in our measurements of the amounts of cell surface receptors. Recycling is generally thought to occur after the agonist has been washed out, but there is evidence for GPCRs recycling back to the plasma membrane both in the presence and absence of agonist (55, 56) . In our experiments, we could not determine whether the agonist hNPY is recycled with the receptor back to the cell surface or whether it is degraded in lysosomes (23, 24) .
Taken together, our data using chimeric EGFP-hNPY Y 1 receptors clearly demonstrate that receptor internalization and recycling can be followed in real time and in a simple manner as a variation of EGFP fluorescence intensity, which reflects receptor trafficking via endocytosis. We were able to detect this signal because, unlike other studies where EGFP was fused to the receptor carboxyl-terminal, we fused EGFP to the extracellular amino-terminal of the hNPY Y 1 receptor, as previously for the NK2 neurokinin receptor (31) . In terms of pharmacological characterization of receptor ligands, such a measurement represents a straightforward method to determine rapidly the capacity of ligands to promote receptor internalization, recycling, and degradation. In our case, the changes in EGFPhNPY Y 1 receptor fluorescence reflect the agonist, partial agonist, or antagonist character of the ligands used.
As presented in Fig. 9 , based on our mean data and a simplified scheme, we derived a multicompartment model of internalization and recycling to describe the hNPY-induced variations in fluorescence. In our model, we assume that internalized EGFP-hNPY Y 1 receptors may recycle either from early endosomes and/or from recycling endosomes (Fig. 8C) , as also recently proposed for vasopressin receptor trafficking (57) . At a given time t, the relative fluorescence I(t) is given by, 2 , respectively, are in good agreement with t1 ⁄2 values of 5 and 9 -12 min reported for markers (like transferrin) of internalization and recycling, respectively, via the clathrin-coated pits pathway (43) . This strongly supports that EGFP-hNPY Y 1 receptor trafficking in HEK293 cells uses the same pathway. It is noteworthy that using a previously described two-compartment model (36) , the fit to our data was significantly poorer (not shown). Our approach is powerful in that it allows determination of all parameters from a single experiment and discriminates two recycling processes. In agreement with our confocal data, the model predicts that early endosomes are rapidly populated, reaching a plateau within 5 min, while the recycling compartment fills more slowly with time. At the same time, it can be concluded that over the first 30 min, the early endosomal compartment constitutes the major recycling pathway. These conclusions are in line with the recent proposal of short and long recycling pathways for vasopressin receptor trafficking (57) . Finally, our model should be considered as a minimal scheme that is required to adequately fit the data, and does not of course, exclude more complicated models. Our experimental approach and the model we developed should provide new information on the kinetics of receptor endocytosis and recycling. For instance, NK2 receptors aminoterminal labeled with EGFP follow the same endocytic pathway as EGFP-hNPY Y 1 receptors, but with much slower kinetics. 2 Furthermore, as demonstrated here by using tools interfering with activation and specific endocytic pathways, this technique allows dissection of the molecular components of the internalization mechanism.
In conclusion, we provide evidence that rapid desensitization of hNPY Y 1 receptors following acute agonist exposure may result from rapid internalization of receptor via clathrin-coated pits. We describe a method based on ligand-stimulated variations of EGFP-receptor fluorescence that allows real time assessment of the dynamic regulation of GPCR signaling and estimation of both internalization and recycling rate constants using a multicompartment model. This assay is sensitive, rapid, and easily performed. It should be applicable to nearly all GPCRs and potentially represents a powerful approach for identifying ligands, since neither detailed biochemical and pharmacological data nor prior knowledge of other signaling events are required.
